• New Malaria Vaccines Offer Hope for Eradication

  • Feb 26 2025
  • Length: 3 mins
  • Podcast

New Malaria Vaccines Offer Hope for Eradication

Listen for free

View show details

  • Summary

  • In the ongoing battle against malaria, recent developments have brought significant hope and progress, particularly in the realm of vaccine development.

    A groundbreaking study published in the _New England Journal of Medicine_ has highlighted the promising results of a new malaria vaccine, GA2, developed by researchers at Leiden University Medical Center and Radboud University Medical Center in the Netherlands. This late-liver-stage attenuated malaria parasite vaccine has shown high protective efficacy against malaria infection. The vaccine, which involves immunization with a genetically modified _Plasmodium falciparum_ parasite, induced a favorable immune response and provided substantial protection in a small clinical trial. In the trial, 89% of participants who received the GA2 vaccine were protected against malaria, compared to 13% in the control group and none in the placebo group. This vaccine's mechanism involves exposing the immune system to a broader range of parasite antigens, enhancing the immune response and preventing breakthrough infections[1].

    In another significant advancement, researchers at the Seattle Children’s Research Institute, in collaboration with the biotechnology company Sanaria, have developed a novel malaria vaccine called PfSPZ-LARC2. This vaccine, engineered through the deletion of two parasite genes, allows the parasite to multiply in the liver without causing symptoms, thereby stimulating a strong immune response. The PfSPZ-LARC2 vaccine has shown 100% protection against infection in animal models and is now poised for clinical trials. This vaccine has the potential to save millions of lives and could be a crucial tool in mass vaccination programs aimed at eliminating malaria from defined geographic regions[2].

    Current malaria vaccines, such as RTS,S, which was recommended by the World Health Organization (WHO) in 2021, have also seen expanded implementation. RTS,S has been shown to reduce deaths among children by 13% and severe malaria hospitalizations by 22%. As of January 2024, Cameroon became the first non-pilot country to introduce RTS,S into its routine immunization program, with at least nine countries expected to be using it by 2025[5].

    These developments underscore the urgent need for more effective and durable vaccination strategies against malaria, a disease that still claims nearly half a million lives annually, predominantly in sub-Saharan Africa and parts of Asia and Latin America. The ongoing research and advancements in malaria vaccines are critical steps towards achieving the global goal of malaria eradication and highlight the collaborative efforts of researchers, health organizations, and governments in combating this devastating disease.
    Show More Show Less
Show More Show Less

What listeners say about New Malaria Vaccines Offer Hope for Eradication

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available